Arrowstreet Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $367M | Buy |
|
|||||
|
2025
Q1 | $372M | Buy |
|
|||||
|
2024
Q4 | $258M | Sell |
|
|||||
|
2024
Q3 | $411M | Sell |
|
|||||
|
2024
Q2 | $506M | Buy |
|
|||||
|
2024
Q1 | $419M | Buy |
|
|||||
|
2023
Q4 | $341M | Sell |
|
|||||
|
2023
Q3 | $402M | Buy |
|
|||||
|
2023
Q2 | $382M | Buy |
|
|||||
|
2023
Q1 | $391M | Sell |
|
|||||
|
2022
Q4 | $461M | Sell |
|
|||||
|
2022
Q3 | $482M | Buy |
|
|||||
|
2022
Q2 | $445M | Buy |
|
|||||
|
2022
Q1 | $373M | Buy |
|
|||||
|
2021
Q4 | $38M | Sell |
|
|||||
|
2021
Q3 | $62.3M | Buy |
|
|||||
|
2021
Q2 | $2.44M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $725K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $11.7M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $2.84M | Buy |
|
|||||
|
2019
Q2 | $1.08M | Sell |
|
|||||
|
2019
Q1 | $17.8M | Buy |
|
|||||
|
2018
Q4 | $945K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $188M | Sell |
|
|||||
|
2017
Q4 | $396M | Sell |
|
|||||
|
2017
Q3 | $344M | Buy |
|
|||||
|
2017
Q2 | $200M | Buy |
|
|||||
|
2017
Q1 | $134M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $80.5M | Buy |
|
|||||
|
2016
Q2 | $73.4M | Buy |
|
|||||
|
2016
Q1 | $18.4M | Buy |
|
|||||
|
2015
Q4 | $6.75M | Sell |
|
|||||
|
2015
Q3 | $57.6M | Sell |
|
|||||
|
2015
Q2 | $96.9M | Buy |
|
|||||
|
2015
Q1 | $88.4M | Sell |
|
|||||
|
2014
Q4 | $114M | Buy |
|
|||||
|
2014
Q3 | $66.2M | Buy |
|
|||||
|
2014
Q2 | $8.89M | Sell |
|
|||||
|
2014
Q1 | $22.5M | Buy |
|
|||||
|
2013
Q4 | $11.8M | Buy |
|
|||||
|
2013
Q3 | $3.72M | Buy |
|